Canada markets closed

Rocket Pharmaceuticals, Inc. (RCKT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
23.47+0.70 (+3.07%)
At close: 04:00PM EDT
23.47 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.13B
Enterprise Value 1.78B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.32
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -7.53

Trading Information

Stock Price History

Beta (5Y Monthly) 1.06
52-Week Change 36.60%
S&P500 52-Week Change 322.38%
52 Week High 332.53
52 Week Low 314.89
50-Day Moving Average 326.03
200-Day Moving Average 323.13

Share Statistics

Avg Vol (3 month) 3737.76k
Avg Vol (10 day) 3765.99k
Shares Outstanding 590.75M
Implied Shares Outstanding 690.75M
Float 870.45M
% Held by Insiders 13.43%
% Held by Institutions 1101.20%
Shares Short (Apr 15, 2024) 411M
Short Ratio (Apr 15, 2024) 416.43
Short % of Float (Apr 15, 2024) 415.84%
Short % of Shares Outstanding (Apr 15, 2024) 412.16%
Shares Short (prior month Mar 15, 2024) 410.24M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 05, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jan 05, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-29.03%
Return on Equity (ttm)-50.01%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -252.56M
Net Income Avi to Common (ttm)-245.6M
Diluted EPS (ttm)-2.92
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)373.18M
Total Cash Per Share (mrq)4.12
Total Debt (mrq)25.04M
Total Debt/Equity (mrq)5.08%
Current Ratio (mrq)7.80
Book Value Per Share (mrq)5.46

Cash Flow Statement

Operating Cash Flow (ttm)-194.92M
Levered Free Cash Flow (ttm)-121.64M